Funded Startups in Wauwatosa
Wauwatosa’s most recent disclosed funding amounts are small-scale relative to one standout: RoddyMedical’s $5M Series A on 2025-12-11 is the only disclosed…
Wauwatosa’s most recent disclosed funding amounts are small-scale relative to one standout: RoddyMedical’s $5M Series A on 2025-12-11 is the only disclosed round above $500K, while the other disclosed amounts shown are $500K (Voyager AI, 2026-03-11) and $250K (GenoPalate, 2026-03-04). In the same five-row slice, four of five companies are in regulated-facing categories (Financial Services: Voyager AI on 2026-03-11 and CrossKudi on 2022-11-14; Biotechnology: GenoPalate on 2026-03-04; Health Care: RoddyMedical on 2025-12-11), but Series classification is uneven: three of five entries are “Series Unknown/undisclosed” (Groupware Technologies 2026-06-08; GenoPalate 2026-03-04; CrossKudi 2022-11-14). Temporally, the disclosed pattern concentrates near the present: three of the five rows fall in 2026 (Groupware Technologies 2026-06-08, Voyager AI 2026-03-11, GenoPalate 2026-03-04), while the oldest row shown is CrossKudi on 2022-11-14.
Most recent rounds
5 shownRelated listings
Frequently asked
What’s the largest disclosed round in Wauwatosa here, and how does it compare to the rest of the disclosed amounts?
RoddyMedical’s $5M Series A (2025-12-11) is an outlier: it’s the only disclosed amount above $500K. The other disclosed rounds are $500K (Voyager AI, 2026-03-11) and $250K (GenoPalate, 2026-03-04).
Are funding events clustered in time within these five Wauwatosa entries?
Yes. Three of the five rows date to 2026 (Groupware Technologies on 2026-06-08, Voyager AI on 2026-03-11, GenoPalate on 2026-03-04). The remaining dates are 2025-12-11 (RoddyMedical) and 2022-11-14 (CrossKudi).
Which sectors are most represented across the companies listed?
Financial Services appears twice: Voyager AI (2026-03-11) and CrossKudi (2022-11-14). The other three sectors are singletons in this slice: Biotechnology (GenoPalate, 2026-03-04), Health Care (RoddyMedical, 2025-12-11), and Other (Groupware Technologies, 2026-06-08).
How much of the list has undisclosed or “Series Unknown” classifications, and does that affect stage visibility?
Stage/amnt disclosure is limited: Groupware Technologies (2026-06-08) is “undisclosed” and RoddyMedical is the only entry with a named series plus a disclosed amount ($5M Series A, 2025-12-11). Two additional rows have “Series Unknown” with disclosed amounts (GenoPalate, $250K on 2026-03-04; Voyager AI, $500K on 2026-03-11), and CrossKudi (2022-11-14) is “undisclosed.”
Are there outliers worth focusing on beyond the largest round size?
The biggest difference is disclosure and recency rather than geography, since all five entries are listed in Wauwatosa, Wisconsin. On the financial side, RoddyMedical’s $5M (2025-12-11) stands far above the next disclosed round at $500K (Voyager AI, 2026-03-11), while two entries are “undisclosed” entirely (Groupware Technologies, 2026-06-08; CrossKudi, 2022-11-14).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.